Multicancer Early Detection Blood Tests Are Feasible
FRIDAY, Oct. 6, 2023 (HealthDay News) -- Multicancer early detection (MCED) blood tests are feasible for detecting cancer, according to a study published online Oct. 5 in The Lancet.
Deb Schrag, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a prospective cohort study to examine the feasibility of MCED testing for cancer screening in a convenience sample of adults aged 50 years or older without signs or symptoms of cancer. A total of 6,662 participants were recruited between Dec. 12, 2019, and Dec. 4, 2020; 6,621 had analyzable results.
The researchers detected a cancer signal in 1.4 percent of participants with analyzable results. Of these, 38 percent were diagnosed with cancer (true positives) and 62 percent had no cancer diagnosis (false positives). The median time to diagnostic resolution was 79 days: 57 and 162 days in true-positive and false-positive participants, respectively. Most of the participants had laboratory tests (79 and 88 percent with true-positive and false-positive results, respectively) and imaging (91 and 93 percent, respectively). In participants with false-positive results, fewer procedures were conducted than in those with true-positive results (30 versus 82 percent).
"Although this study establishes clinical feasibility of MCED testing, forthcoming results of larger studies will be required to show clinical utility and effects on cancer mortality," the authors write.
Several authors disclosed ties to biotechnology and pharmaceutical companies, including GRAIL, which funded the trial.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
‘Vaginal Seeding’ Could Give Health Boost to Babies Born Via C-Section
THURSDAY, June 15, 2023 (HealthDay News) -- Vaginal "seeding" may be a safe way...
Sexual Issues Can Plague Young Women Who’ve Survived Cancer
MONDAY, Oct. 3, 2022 (HealthDay News) -- Young women who have survived cancer...
Clinical Guideline Developed for Use of Biomarkers in Ulcerative Colitis
FRIDAY, March 17, 2023 (HealthDay News) -- In a clinical practice guideline...
Los anticuerpos por la infección con la COVID protegen a los niños durante hasta 7 meses
MARTES, 22 de marzo de 2022 (HealthDay News) -- Los anticuerpos de una infección...